Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House approves bill to allow FDA‑approved crystalline psilocybin despite lawmakers’ safety concerns
Summary
On Jan. 23, 2025 the House approved House Bill 1063 to permit lawful use of crystalline polymorph psilocybin approved by the U.S. Food and Drug Administration. Some members urged caution and stronger implementation guardrails, citing potential mental‑health risks and the need to define controlled treatment settings.
House Bill 1063, which concerns the lawful use of crystalline polymorph psilocybin that is approved by the United States Food and Drug Administration (FDA), was adopted by the House on third reading on Jan. 23, 2025.
The bill was presented for third reading by the majority leader. Representative de Graaf urged a no vote, warning that the state may be “2 to 3 years out” from implementation and that adopting statutory approval now without regulatory guardrails could be premature. “There is the potential for…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
